STOCK TITAN

Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter

(Neutral)
(Neutral)
Tags
earnings date

Kewaunee Scientific (NASDAQ: KEQU) will release financial results for its fourth quarter and fiscal year ended April 30, 2026 on Tuesday, June 23, 2026, after the close of trading.

According to Kewaunee Scientific, results will be posted on its website and will reflect its expanded portfolio including newly acquired subsidiary Nu Aire.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – KEQU

-0.61%
-0.61% Session close to close

In the Jun 11 session, KEQU declined 0.61%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

STATESVILLE, N.C., June 10, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal year ended April 30, 2026 on Tuesday, June 23, 2026 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release.

Kewaunee Scientific Corporation (PRNewsFoto/Kewaunee Scientific Corporation)

About Kewaunee Scientific

Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, Spain, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. 

Kewaunee Scientific's newly acquired subsidiary, Nu Aire, is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products that complement the Kewaunee Scientific portfolio. Founded in 1971, Nu Aire's headquarters and manufacturing facilities are located in Plymouth, Minnesota, with additional manufacturing capabilities located in Long Lake, Minnesota. The Company also maintains a warehouse partnership in the Netherlands and OEM partnerships in China.

Learn more at the companies' websites, located at http://www.kewaunee.com and http://www.nuaire.com/

This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the Nu Aire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the most recent fiscal year ended April 30, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Donald T. Gardner III


704/871-3274

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kewaunee-scientific-to-report-results-for-fiscal-year-and-fourth-quarter-302797217.html

SOURCE Kewaunee Scientific Corporation

FAQ

When will Kewaunee Scientific (KEQU) report fiscal year 2026 earnings?

Kewaunee Scientific plans to report fiscal year and Q4 2026 results on June 23, 2026, after market close. According to Kewaunee Scientific, the financial results will cover the year ended April 30, 2026 and be posted on the company website.

How can investors access Kewaunee Scientific's Q4 and fiscal 2026 results for KEQU?

Investors can access Kewaunee Scientific’s Q4 and fiscal 2026 results on the company’s website after release. According to Kewaunee Scientific, the earnings report will be posted online following publication on June 23, 2026, after the close of trading.

What does the Nu Aire acquisition mean for Kewaunee Scientific (KEQU) investors?

The Nu Aire acquisition adds biological safety cabinets, CO2 incubators, and ultralow freezers to Kewaunee’s portfolio. According to Kewaunee Scientific, Nu Aire’s Minnesota manufacturing base and complementary lab products broaden the company’s laboratory, healthcare, and technical furniture offerings for global customers.

What products does Kewaunee Scientific (KEQU) focus on before the 2026 earnings release?

Kewaunee Scientific focuses on laboratory, healthcare, and technical furniture, including steel and wood casework and fume hoods. According to Kewaunee Scientific, its range also includes modular systems, workstations, benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

Where are Kewaunee Scientific’s main operations and manufacturing facilities located?

Kewaunee Scientific’s headquarters are in Statesville, North Carolina, with sales offices in the US, Spain, India, Saudi Arabia, and Singapore. According to Kewaunee Scientific, it operates three Statesville plants plus a Bangalore facility serving Asian and African laboratory markets.

What risks does Kewaunee Scientific (KEQU) highlight in its forward-looking statements?

Kewaunee cites risks such as realizing Nu Aire acquisition benefits, economic conditions, supply constraints, and regulatory changes. According to Kewaunee Scientific, additional risks include international operations, raw material costs, and force majeure events, outlined further in its Form 10-K and other SEC filings.